Corient Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$11.2M Hold
63,040
0.84% 18
2022
Q2
$11.2M Buy
63,040
+6,671
+12% +$1.19M 0.85% 20
2022
Q1
$9.99M Buy
56,369
+3,996
+8% +$680K 0.66% 28
2021
Q4
$8.96M Buy
52,373
+536
+1% +$87.8K 0.59% 35
2021
Q3
$8.37M Buy
51,837
+570
+1% +$97.2K 0.61% 36
2021
Q2
$8.45M Buy
51,267
+2,325
+5% +$385K 0.62% 31
2021
Q1
$8.04M Buy
48,942
+867
+2% +$140K 0.69% 25
2020
Q4
$7.57M Sell
48,075
-7,000
-13% -$1.03M 0.76% 27
2020
Q3
$8.2M Buy
55,075
+821
+2% +$121K 0.94% 14
2020
Q2
$7.63M Buy
54,254
+3,142
+6% +$458K 0.93% 15
2020
Q1
$6.7M Buy
51,112
+601
+1% +$85.3K 1.06% 14
2019
Q4
$7.37M Buy
50,511
+1,646
+3% +$223K 0.94% 15
2019
Q3
$6.32M Buy
48,865
+758
+2% +$99.9K 0.9% 16
2019
Q2
$6.7M Buy
48,107
+3,026
+7% +$419K 1.03% 10
2019
Q1
$6.3M Buy
45,081
+10,738
+31% +$1.44M 1.02% 10
2018
Q4
$4.43M Buy
34,343
+10,416
+44% +$1.45M 0.79% 22
2018
Q3
$3.31M Hold
23,927
0.55% 41
2018
Q2
$2.9M Buy
23,927
+9,803
+69% +$1.22M 0.51% 52
2018
Q1
$1.81M Buy
14,124
+872
+7% +$118K 0.33% 87
2017
Q4
$1.85M Buy
13,252
+18
+0.1% +$2.51K 0.32% 89
2017
Q3
$1.72M Sell
13,234
-132,387
-91% -$17.5M 0.33% 86
2017
Q2
$19.3M Buy
145,621
+287
+0.2% +$36.6K 2.95% 4
2017
Q1
$18.1M Sell
145,334
-42
-0% -$5.02K 2.82% 5
2016
Q4
$16.7M Buy
145,376
+1,787
+1% +$206K 2.96% 5
2016
Q3
$17M Buy
+143,589
New +$17.4M 3.14% 5

Other funds holding JNJ

Corient Capital Partners's JNJ Position: Q3 2022 in Review

Corient Capital Partners held its Johnson & Johnson (JNJ) position steady in Q3 2022 at 63,040 shares worth $11.2M. The position accounts for 0.84% of the portfolio, ranked #18.

Corient Capital Partners first reported a position in JNJ in Q3 2016 and has held it in 25 quarters since. The position peaked at $19.3M in Q2 2017. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Corient Capital Partners held 63,040 shares of Johnson & Johnson worth $11.2M as of Q3 2022.
  • Corient Capital Partners left its Johnson & Johnson share count unchanged in Q3 2022.
  • Johnson & Johnson made up 0.84% of Corient Capital Partners's portfolio in Q3 2022, its #18 holding.
  • Corient Capital Partners first reported a position in Johnson & Johnson in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's Johnson & Johnson position peaked at $19.3M in Q2 2017.
  • 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.